CytoTools AG | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
50.00
300.50
-
-
89.80
Cost of Goods Sold (COGS) incl. D&A
548.50
337.30
13.00
19.10
451.90
Gross Income
498.50
36.80
13.00
19.10
362.10
SG&A Expense
700.50
1,126.10
1,291.50
959.30
658.70
EBIT
1,199.20
1,163.30
1,305.00
978.80
1,017.60
Unusual Expense
-
4.70
-
-
-
Non Operating Income/Expense
39.90
122.90
-
-
59.10
Interest Expense
-
-
0.10
-
-
Pretax Income
1,135.10
1,035.10
1,304.00
978.70
1,065.20
Consolidated Net Income
1,135.10
1,035.10
1,304.00
978.70
1,065.20
Net Income
1,135.10
1,035.10
1,304.00
978.70
1,065.20
Net Income After Extraordinaries
1,135.10
1,035.10
1,304.00
978.70
1,065.20
Net Income Available to Common
1,135.10
1,035.10
1,304.00
978.70
1,065.20
EPS (Basic)
0.61
0.55
0.66
0.49
0.50
Basic Shares Outstanding
1,870.00
1,892.00
1,986.00
2,000.00
2,120.30
EPS (Diluted)
0.61
0.55
0.66
0.49
0.50
Diluted Shares Outstanding
1,870.00
1,892.00
1,986.00
2,000.00
2,120.30
EBITDA
1,186.10
1,149.70
1,292.00
959.70
981.10
Other Operating Expense
0.10
0.40
0.50
0.30
3.20
Non-Operating Interest Income
24.10
10.00
1.10
0.10
11.40
About CytoTools
View Profile
